Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

FDA sued over ‘reckless and arbitrary’ semaglutide decision
The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.
FDA clears Google smartwatch tech that calls 911 when a user’s heart stops
Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
The years-long shortage of Wegovy and Ozempic, two popular prescription-only semaglutide injections, is officially over.
FDA approves first rapid-acting insulin biosimilar for diabetes
Sanofi's Merilog is a new biosimilar substitute for Novo Nordisk’s NovoLog. It can be used to treat adult and pediatric patients with type 1 and type 2 diabetes.
Aspartame linked to surging insulin levels, fatty plaques and inflammation
Aspartame, the artificial sweetener commonly found in diet sodas and sugar-free snacks, may do significant harm to a person’s cardiovascular system.

New drug combination could lead to the return of an old diabetes treatment

Rosiglitazone was once a popular treatment for Type 2 diabetes, but it fell out of favor due to a variety of side effects.

The eye-opening connection between heart health and cognitive decline

The World Health Organization estimates that 82 million people will be affected by dementia by the year 2030—could maintaining a healthy heart be one way to keep such conditions at bay?

Sugary drink consumption boosts risk of CVD, stroke in women

Drinking just one sugary drink per day can increase a woman’s risk of cardiovascular disease (CVD) by 19%, according to new findings published in the Journal of the American Heart Association.

Cardiovascular groups share joint guidance on continuation of procedures, diagnostic tests during COVID-19 pandemic

A group of cardiovascular societies, including the American College of Cardiology (ACC) and American Heart Association (AHA), has published a new guidance designed to help providers resume important procedures and diagnostic tests during the COVID-19 pandemic.

New CDC data finds hypertension on the rise—but it’s not what you think

There’s a reason to feel quite optimistic about these numbers—the rise comes from an updated definition of hypertension, one first suggested by the American College of Cardiology and American Heart Association.

Evolocumab associated with significant drop in heart attack risk

Taking evolocumab to lower LDL cholesterol can lead to significant reductions in a patient’s risk of myocardial infarction (MI), according to new findings published by JAMA Cardiology.

How do blood pressure medications affect coronavirus patients? Specialists hope to crack the code

Researchers have launched a new multi-center clinical trial aimed at learning more about how various blood pressure medications impact the health of patients with COVID-19.

Embracing salt substitutes could help China prevent 450K CVD deaths per year

The team also found that such a shift could prevent more than 740,000 non-fatal CVD events annually and decrease new chronic kidney disease cases by nearly 7%.

Heart Health

FDA sued over ‘reckless and arbitrary’ semaglutide decision

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops

FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic

FDA approves first rapid-acting insulin biosimilar for diabetes

Aspartame linked to surging insulin levels, fatty plaques and inflammation